
Ketchem Biotherapeutics Consulting LLC specializes in providing expert guidance for biotherapeutic discovery and design. They offer services such as scientific advising, therapeutic project consultation, computational structural biology, antibody discovery technologies, antibody engineering, humanization, optimization, biotherapeutic modality design, molecular design and modeling, and biologics software platform direction. A key highlight is their involvement in the invention of Evolocumab, an immunotherapy medication, and leading the development of the J.HAL® AI-driven antibody discovery platform. They also contributed to rescuing the developability of MAM01 for malaria prophylaxis and are inventors of AI-driven methods for ranking and optimizing antibody sequences. Their business model appears to be based on consulting services.

Ketchem Biotherapeutics Consulting LLC specializes in providing expert guidance for biotherapeutic discovery and design. They offer services such as scientific advising, therapeutic project consultation, computational structural biology, antibody discovery technologies, antibody engineering, humanization, optimization, biotherapeutic modality design, molecular design and modeling, and biologics software platform direction. A key highlight is their involvement in the invention of Evolocumab, an immunotherapy medication, and leading the development of the J.HAL® AI-driven antibody discovery platform. They also contributed to rescuing the developability of MAM01 for malaria prophylaxis and are inventors of AI-driven methods for ranking and optimizing antibody sequences. Their business model appears to be based on consulting services.